Keywords: Merck & Co, Fosamax, Damages award, Osteoporosis

Merck & Co challenges verdict awarding $8 million damages in Fosamax case

Article | 28 June 2010

Print This

US drug giant Merck & Co said on Friday that it is challenging the decision returned by a New York ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in